Hologic expands its digital radiography role

Article

Hologic finalized its acquisition of the U.S. business assets of Trex Medical (SCAN 8/30/00) earlier this month and will use these assets to reposition itself as a full-line, digital-focused x-ray supplier, according to S. David Ellenbogen,

Hologic finalized its acquisition of the U.S. business assets of Trex Medical (SCAN 8/30/00) earlier this month and will use these assets to reposition itself as a full-line, digital-focused x-ray supplier, according to S. David Ellenbogen, chairman and CEO of the Bedford, MA, bone densitometry vendor.

The amorphous selenium flat-panel digital detector technology of Hologic’s Direct Radiography (DRC) subsidiary, acquired a year ago, will be applied to both of Trex’s product lines, mammographic and radiographic, Ellenbogen said.

“The acquisition of Trex is really a scheme of vertical integration,” Ellenbogen told SCAN. “The centerpiece for the strategy will continue to be the plates, which we will use for both radiographic and mammographic purposes.”

Hologic will keep production of the Trex radiographic line, combining manufacture of products formerly sold by Continental X-ray, Bennett X-ray, and XRE, in its Littleton, MA, facility but will market this equipment under the Hologic label. The Lorad label will be continued for the mammographic products produced in Danbury, CT.

As one of his first moves to reposition the former Trex business, Ellenbogen hired Jack Cumming as Lorad president. Cumming is a veteran medical imaging industry analyst who runs his own company, HealthCare Markets Group, out of Hilton Head, SC.

Hologic plans to take over the Trex booth at the upcoming RSNA meeting, Ellenbogen said. The firm will show initial work on converting the former Trex digital mammography technology over to the DRC flat-panel detector, although this work-in-progress system will also be on display with its original CCD-based detectors.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.